Literature DB >> 25744679

Synaptic inhibition and disinhibition in the spinal dorsal horn.

Steven A Prescott1.   

Abstract

Nociceptive signals originating in the periphery must be transmitted to the brain to evoke pain. Rather than being conveyed unchanged, those signals undergo extensive processing in the spinal dorsal horn. Synaptic inhibition plays a crucial role in that processing. On the one hand, neuropathy and inflammation are associated with reduced spinal inhibition; on the other hand, the hypersensitivity associated with inflammatory and neuropathic pain can be reproduced by blocking inhibition at the spinal level. To understand the consequences of disinhibition and how to therapeutically reverse it, one must understand how synaptic inhibition normally operates. To that end, this chapter will discuss the structure and function of GABAA and glycine receptors together with the role of associated molecules involved in transmitter handling and chloride regulation. Mechanisms by which inhibition modulates cellular excitability will be described. The chapter will end with discussion of how inhibition goes awry under pathological conditions and what the implications are for the treatment of resulting pain.
© 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Bicarbonate; Chloride; Disinhibition; Dorsal horn; GABA; Glycine; Inhibition; Interneuron; KCC2; Spinal cord

Mesh:

Substances:

Year:  2015        PMID: 25744679     DOI: 10.1016/bs.pmbts.2014.11.008

Source DB:  PubMed          Journal:  Prog Mol Biol Transl Sci        ISSN: 1877-1173            Impact factor:   3.622


  17 in total

1.  Timing Mechanisms Underlying Gate Control by Feedforward Inhibition.

Authors:  Yan Zhang; Shenbin Liu; Yu-Qiu Zhang; Martyn Goulding; Yan-Qing Wang; Qiufu Ma
Journal:  Neuron       Date:  2018-08-16       Impact factor: 17.173

Review 2.  The H-Reflex as a Biomarker for Spinal Disinhibition in Painful Diabetic Neuropathy.

Authors:  Corinne Lee-Kubli; Andrew G Marshall; Rayaz A Malik; Nigel A Calcutt
Journal:  Curr Diab Rep       Date:  2018-01-23       Impact factor: 4.810

3.  Chronic Pain Releases Parabrachial Activity from Central Amygdala Inhibition.

Authors:  Pia-Kelsey O'Neill; Jozsef Meszaros
Journal:  J Neurosci       Date:  2020-10-14       Impact factor: 6.167

4.  An Amygdalo-Parabrachial Pathway Regulates Pain Perception and Chronic Pain.

Authors:  Charles Raver; Olivia Uddin; Yadong Ji; Ying Li; Nathan Cramer; Carleigh Jenne; Marisela Morales; Radi Masri; Asaf Keller
Journal:  J Neurosci       Date:  2020-03-26       Impact factor: 6.167

5.  Neuroligin 2 regulates spinal GABAergic plasticity in hyperalgesic priming, a model of the transition from acute to chronic pain.

Authors:  Ji-Young V Kim; Salim Megat; Jamie K Moy; Marina N Asiedu; Galo L Mejia; Josef Vagner; Theodore J Price
Journal:  Pain       Date:  2016-06       Impact factor: 7.926

6.  Neuropathic pain after chronic nerve constriction may not correlate with chloride dysregulation in mouse trigeminal nucleus caudalis neurons.

Authors:  Alberto Castro; Ying Li; Charles Raver; Ramesh Chandra; Radi Masri; Mary K Lobo; Asaf Keller
Journal:  Pain       Date:  2017-07       Impact factor: 7.926

7.  Cortical Regulation of Nociception of the Trigeminal Nucleus Caudalis.

Authors:  Alberto Castro; Charles Raver; Ying Li; Olivia Uddin; David Rubin; Yadong Ji; Radi Masri; Asaf Keller
Journal:  J Neurosci       Date:  2017-10-24       Impact factor: 6.709

8.  Excitatory neurons are more disinhibited than inhibitory neurons by chloride dysregulation in the spinal dorsal horn.

Authors:  Kwan Yeop Lee; Stéphanie Ratté; Steven A Prescott
Journal:  Elife       Date:  2019-11-19       Impact factor: 8.140

9.  LIFU Alleviates Neuropathic Pain by Improving the KCC2 Expression and Inhibiting the CaMKIV-KCC2 Pathway in the L4-L5 Section of the Spinal Cord.

Authors:  Ye-Hui Liao; Bin Wang; Mo-Xian Chen; Yao Liu; Li-Juan Ao
Journal:  Neural Plast       Date:  2021-04-13       Impact factor: 3.599

Review 10.  Experimental Drugs for Neuropathic Pain.

Authors:  Kinga Salat; Beata Gryzlo; Katarzyna Kulig
Journal:  Curr Neuropharmacol       Date:  2018       Impact factor: 7.363

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.